{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:36:33Z","timestamp":1772807793817,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3629,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Janssen-Cilag"},{"name":"Israel Society of Hematology"},{"name":"Blood Transfusion"},{"DOI":"10.13039\/501100003975","name":"Israel Cancer Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003975","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.exphem.2012.02.003","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T12:15:31Z","timestamp":1330344931000},"page":"540-547.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Alteration of lipids and the transcription of lipid-related genes in myelodysplastic syndromes via a TP53-related pathway"],"prefix":"10.1016","volume":"40","author":[{"given":"Martin H.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lior","family":"Baraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviv","family":"Shaish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Har-Zahav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dror","family":"Harats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osnat","family":"Ashur-Fabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2012.02.003_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/102453311X12940641877966","article-title":"Cytogenetic abnormalities in myelodysplastic syndrome: an overview","volume":"16","author":"Kawankar","year":"2001","journal-title":"Hematology"},{"key":"10.1016\/j.exphem.2012.02.003_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/152581600319469","article-title":"The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes","volume":"9","author":"Allampallam","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.exphem.2012.02.003_bib3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1172\/JCI110849","article-title":"Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein","volume":"71","author":"Kesaniemi","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2012.02.003_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2007.08.005","article-title":"Living with p53, dying of p53","volume":"130","author":"Aylon","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2012.02.003_bib5","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/sj.onc.1210294","article-title":"Transcription regulation by mutant p53","volume":"26","author":"Weisz","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2012.02.003_bib6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","article-title":"Live or let die: the cell's response to p53","volume":"2","author":"Vousden","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2012.02.003_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2012.02.003_bib8","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2012.02.003_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/156652411797536732","article-title":"Cytogenetic and molecular abnormalities in myelodysplastic syndrome","volume":"11","author":"Nagoshi","year":"2011","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.exphem.2012.02.003_bib10","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.4161\/cc.9.18.12993","article-title":"apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53","volume":"9","author":"Ashur-Fabian","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exphem.2012.02.003_bib11","doi-asserted-by":"crossref","first-page":"E429","DOI":"10.1152\/ajpendo.00178.2011","article-title":"Gut-liver interaction in triglyceride-rich lipoprotein metabolism","volume":"301","author":"Xiao","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.exphem.2012.02.003_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrm2336","article-title":"Cellular cholesterol trafficking and compartmentalization","volume":"9","author":"Ikonen","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2012.02.003_bib13","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.exphem.2012.02.003_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0895-4356(92)90089-6","article-title":"Prospective study of serum cholesterol and site-specific cancers","volume":"45","author":"Chyou","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.exphem.2012.02.003_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0019-509X.12341","article-title":"Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions","volume":"41","author":"Patel","year":"2004","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.exphem.2012.02.003_bib16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1046\/j.1365-2141.1999.01701.x","article-title":"Increased macrophages, high serum M-CSF and low serum cholesterol in myelodysplasia and Kawasaki disease","volume":"106","author":"Shetty","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2012.02.003_bib17","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jn\/136.6.1472","article-title":"A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin\/nicotinamide-induced type 2 diabetes","volume":"136","author":"Chen","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/j.exphem.2012.02.003_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1096\/fj.01-0653fje","article-title":"Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women","volume":"16","author":"Plat","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.exphem.2012.02.003_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-2275(20)32008-3","article-title":"Diurnal and dietary-induced changes in cholesterol synthesis correlate with levels of mRNA for HMG-CoA reductase","volume":"41","author":"Jurevics","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.exphem.2012.02.003_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.6261329","article-title":"Regulation of plasma cholesterol by lipoprotein receptors","volume":"212","author":"Brown","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.exphem.2012.02.003_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V86.1.268.bloodjournal861268","article-title":"Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes","volume":"86","author":"Raza","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.003_bib22","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/sj.leu.2401959","article-title":"Expression and activity of caspases 1 and 3 in myelodysplastic syndromes","volume":"14","author":"Boudard","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.02.003_bib23","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0145-2126(00)00062-X","article-title":"P53 overexpression in bone marrow biopsies in refractory anemia and aplastic anemia: impact of antibody selection","volume":"24","author":"Elghetany","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2012.02.003_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/sj.leu.2400980","article-title":"Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia","volume":"12","author":"Kitagawa","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.02.003_bib25","first-page":"338","article-title":"p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia","volume":"145","author":"Kitagawa","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2012.02.003_bib26","first-page":"726","article-title":"bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis","volume":"9","author":"Lepelley","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.02.003_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01715051","article-title":"Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS)","volume":"67","author":"Neubauer","year":"1993","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2012.02.003_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000040984","article-title":"Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia","volume":"102","author":"Kurotaki","year":"2000","journal-title":"Acta Haematol"},{"key":"10.1016\/j.exphem.2012.02.003_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1749-6632.2000.tb06705.x","article-title":"The p53 tumor suppressor gene: from molecular biology to clinical investigation","volume":"910","author":"Soussi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.exphem.2012.02.003_bib30","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/emboj.2011.124","article-title":"Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53","volume":"30","author":"Ugalde","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2012.02.003_bib31","first-page":"327","article-title":"p53 induction and apoptosis in response to radio- and chemotherapy in\u00a0vivo is tumor-type-dependent","volume":"61","author":"Kemp","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2012.02.003_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1203\/00006450-200202000-00020","article-title":"Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of L-carnitine","volume":"51","author":"Hong","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.exphem.2012.02.003_bib33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrcardio.2010.121","article-title":"Cardiotoxicity of anticancer treatments: what the cardiologist needs to know","volume":"7","author":"Ewer","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.exphem.2012.02.003_bib34","doi-asserted-by":"crossref","unstructured":"Ammar el SM, Said SA, Suddek GM, El-Damarawy SL. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats. Can J Physiol Pharmacol. 2011;89:269\u2013276.","DOI":"10.1139\/y11-020"},{"key":"10.1016\/j.exphem.2012.02.003_bib35","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fct.2007.12.005","article-title":"Amelioration of anti-cancer agent adriamycin-induced nephrotic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine","volume":"46","author":"He","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.exphem.2012.02.003_bib36","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.fct.2008.03.033","article-title":"Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats","volume":"46","author":"El-Shitany","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.exphem.2012.02.003_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1440-1797.2006.00592.x","article-title":"L-carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats","volume":"11","author":"Boonsanit","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.exphem.2012.02.003_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tox.2005.02.009","article-title":"Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities","volume":"211","author":"Deepa","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.exphem.2012.02.003_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1024175325850","article-title":"The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats","volume":"247","author":"Malarkodi","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.exphem.2012.02.003_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0300-483X(99)00179-1","article-title":"The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats","volume":"143","author":"Badary","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.exphem.2012.02.003_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.fjc.0000171750.97822.a2","article-title":"Modulation by melatonin of the cardiotoxic and antitumor activities of adriamycin","volume":"46","author":"Kim","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.exphem.2012.02.003_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0022-2275(20)41615-3","article-title":"Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in\u00a0vivo","volume":"33","author":"Rudling","year":"1992","journal-title":"J Lipid Res"},{"key":"10.1016\/j.exphem.2012.02.003_bib43","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1172\/JCI117213","article-title":"Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver","volume":"93","author":"Powell","year":"1994","journal-title":"J Clin Invest"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X12000823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X12000823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:30:08Z","timestamp":1759566608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X12000823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0301472X12000823"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2012.02.003","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alteration of lipids and the transcription of lipid-related genes in myelodysplastic syndromes via a TP53-related pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2012.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}